Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors

Immune checkpoint blockade (ICB) has emerged as a novel therapeutic tool for cancer therapy in the last decade. Unfortunately, a small number of patients benefit from approved immune checkpoint inhibitors (ICIs). Therefore, multiple studies are being conducted to find new ICIs and combination strate...

Full description

Bibliographic Details

Published in:	Biology
Main Authors:	Shovan Dutta, Anirban Ganguly, Kaushiki Chatterjee, Sheila Spada, Sumit Mukherjee
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	cancer treatment immune response cancer therapeutic strategy tumor immune escape immune-oncology tumor immune microenvironment
Online Access:	https://www.mdpi.com/2079-7737/12/2/218